Latest Insider Transactions at Kymera Therapeutics, Inc. (KYMR)
This section provides a real-time view of insider transactions for Kymera Therapeutics, Inc. (KYMR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kymera Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kymera Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
680
+0.15%
|
$1,360
$2.08 P/Share
|
|
Jul 28
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,864
-0.85%
|
$231,840
$60.15 P/Share
|
|
Jul 28
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,864
+0.84%
|
$7,728
$2.08 P/Share
|
|
Jul 26
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,015
-1.95%
|
$540,900
$60.15 P/Share
|
|
Jul 26
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,015
+1.92%
|
$18,030
$2.08 P/Share
|
|
Jul 08
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
48,000
-2.47%
|
$2,400,000
$50.37 P/Share
|
|
Jul 08
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,000
+8.76%
|
$96,000
$2.08 P/Share
|
|
Jul 01
2021
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
544,166
+13.94%
|
$25,575,802
$47.0 P/Share
|
|
Jun 14
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+8.13%
|
$80,000
$2.08 P/Share
|
|
Jun 10
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,009
-1.79%
|
$1,173,459
$51.54 P/Share
|
|
Jun 10
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,009
+5.02%
|
$46,018
$2.08 P/Share
|
|
Jun 09
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,752
-1.38%
|
$287,600
$50.02 P/Share
|
|
Jun 09
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,752
+1.36%
|
$11,504
$2.08 P/Share
|
|
Jun 08
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
270
-0.07%
|
$13,500
$50.0 P/Share
|
|
Jun 08
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
270
+0.07%
|
$540
$2.08 P/Share
|
|
Jun 07
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,724
-2.99%
|
$636,200
$50.14 P/Share
|
|
Jun 07
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,724
+2.91%
|
$25,448
$2.08 P/Share
|
|
Jun 03
2021
|
Bruce N. Jacobs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-35.32%
|
$460,000
$46.9 P/Share
|
|
Jun 03
2021
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+36.69%
|
$20,000
$2.08 P/Share
|
|
May 19
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+3.51%
|
$30,000
$2.08 P/Share
|
|
May 18
2021
|
Atlas Venture Fund X, L.P. |
SELL
Other acquisition or disposition
|
Direct |
1,122,619
-16.3%
|
-
|
|
May 12
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,245
-2.03%
|
$412,250
$50.05 P/Share
|
|
May 12
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,245
+1.99%
|
$16,490
$2.08 P/Share
|
|
Apr 26
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,768
-0.69%
|
$110,720
$40.18 P/Share
|
|
Apr 26
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,768
+0.69%
|
$5,536
$2.08 P/Share
|
|
Apr 23
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
680
-0.17%
|
$27,200
$40.01 P/Share
|
|
Apr 23
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
680
+0.17%
|
$1,360
$2.08 P/Share
|
|
Apr 22
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,959
-2.69%
|
$438,360
$40.26 P/Share
|
|
Apr 22
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,959
+2.61%
|
$21,918
$2.08 P/Share
|
|
Apr 19
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,653
+0.83%
|
$13,306
$2.08 P/Share
|
|
Apr 19
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
653
-0.17%
|
$26,120
$40.0 P/Share
|
|
Apr 15
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,940
-1.25%
|
$197,600
$40.29 P/Share
|
|
Apr 15
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,940
+1.23%
|
$9,880
$2.08 P/Share
|
|
Apr 13
2021
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$14,000
$2.08 P/Share
|
|
Apr 13
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+3.69%
|
$30,000
$2.08 P/Share
|
|
Apr 12
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,267
-1.97%
|
$488,544
$32.81 P/Share
|
|
Apr 12
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,267
+3.75%
|
$30,534
$2.08 P/Share
|
|
Apr 09
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,794
-2.88%
|
$752,202
$33.89 P/Share
|
|
Apr 09
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,794
+5.4%
|
$45,588
$2.08 P/Share
|
|
Apr 08
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,939
-1.29%
|
$347,865
$35.22 P/Share
|
|
Apr 08
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,939
+2.51%
|
$19,878
$2.08 P/Share
|
|
Mar 15
2021
|
Bruce N. Jacobs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,195
-100.0%
|
$491,700
$60.17 P/Share
|
|
Mar 15
2021
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,195
+50.0%
|
$16,390
$2.08 P/Share
|
|
Mar 15
2021
|
Jared Gollob Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,305
-19.5%
|
$618,300
$60.17 P/Share
|
|
Mar 15
2021
|
Jared Gollob Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,800
+12.86%
|
$7,800
$1.31 P/Share
|
|
Mar 12
2021
|
Atlas Venture Associates X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
229,350
-100.0%
|
$12,843,600
$56.5 P/Share
|
|
Mar 12
2021
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
229,350
-100.0%
|
$12,843,600
$56.5 P/Share
|
|
Mar 11
2021
|
Bruce N. Jacobs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,805
-100.0%
|
$108,300
$60.07 P/Share
|
|
Mar 11
2021
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,805
+50.0%
|
$3,610
$2.08 P/Share
|
|
Mar 11
2021
|
Jared Gollob Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,695
-9.44%
|
$281,700
$60.05 P/Share
|